Navigation Links
Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany
Date:12/27/2011

University Hospital is considered to be one of the leading university hospitals in Germany. Twenty-five research institutes working in close cooperation with the Medical Department bear witness to the hospital's strong academic approach. This makes sure that patients coming to the University Hospital for treatment enjoy the benefits resulting from timely implementation of research findings. Every year, around 47,200 and 220,000 patients respectively receive in- and outpatient treatment. The University Hospital possesses special interdisciplinary competence in the fields of neurological science, oncology and cardiovascular medicine.

About Delcath SystemsDelcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for commercial sale of its system in the United States. For more information, please visit the Company's website at http://www.delcath.com/.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board
2. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
3. Delcath to Present at the Lazard Healthcare Conference on November 15
4. Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
5. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
6. FDA Schedules Delcath Pre-New Drug Application Meeting Date
7. Delcath Announces Completion of Regulatory Notification Process in New Zealand
8. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
9. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
10. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
11. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...   MultiVir Inc. ("MultiVir"), a clinical-stage gene ... for the treatment of multiple oncological indications, today announced ... Form S-1 with the U.S. Securities and Exchange Commission ... shares of its common stock. The number of shares ... proposed offering have not yet been determined. MultiVir has ...
(Date:3/30/2015)... Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) ... to the position of Executive Vice President & ... be responsible for all legal, compliance and intellectual property ... BioDelivery Sciences International, Inc., where he was Senior Vice ... management that led that company to over a six ...
(Date:3/30/2015)... Mass. , March 30, 2015 Alere ... rapid diagnostics, issued the following statement today in support ... to Combat Antibiotic-Resistant Bacteria. "As the ... commend President Barack Obama for establishing a ... to address the serious threat of antibiotic resistance. We ...
Breaking Medicine Technology:MultiVir Files Registration Statement for Proposed Initial Public Offering 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria 2
... 19, 2007 /PRNewswire-FirstCall/ --,Allos Therapeutics, Inc. today ... with a favorable opinion of the Committee ... Agency (EMEA),has granted orphan drug designation to ... treatment of patients with,peripheral T-cell lymphoma (PTCL). ...
... -- Median time to pain progression is 66.1 ... for the placebo arm --,Hazard ratio of 0.64 ... the relative risk of pain progression, MARTINSRIED/MUNICH, Germany, ... Colo. -- GPC Biotech AG and,Pharmion Corporation today ...
Cached Medicine Technology:Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 2Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 3Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 4Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 5Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 6
(Date:3/30/2015)... Good Shepherd Children’s Home announces 53rd year of caring for ... Christian-based home, the children learn biblical principles and are taught ... their life. , A day in the life… , ... children begin to awake and prepare for the day ahead. ... Sleepily, she crawls out of bed and scrambles to ...
(Date:3/30/2015)... (PRWEB) March 31, 2015 Healtheminds, a ... wellness services through an innovative, easy to use and ... to create awareness about mental health related issues. The ... addiction to alcohol, tobacco and other drugs. , ... adverse health effects. These include the toxic effects of ...
(Date:3/30/2015)... 30, 2015 Zane Benefits, the ... businesses, announced its latest webinar "Can Tax-Free Premium ... This discussion was conducted by Zane Benefits ... Benefits, there is a massive transition to employer-funded ... selecting a group health plan, employers are now ...
(Date:3/30/2015)... Textile Exchange, a global nonprofit dedicated to sustainability ... latest version of its Responsible Down Standard (RDS) ... applied to any waterfowl-based supply chain to help ensure ... The goal of the RDS is to recognize and ... traceability so that products can be labeled accurately and ...
(Date:3/30/2015)... March 30, 2015 Healthy, radiant skin ... Pharmacy. The staff of pharmacists is specially trained and ... like acne, eczema and other conditions. , Most people ... patient’s dermatologist and/or PCP to tackle most skin conditions ... Pharmacy has employed specialty-trained pharmacists who have experience in ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Children’s Home Announces 53rd Year of Providing a Safe-Haven for Children in Need 2Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Zane Benefits New Webinar Premium Reimbursement Webinar Now Available On-Demand 2Health News:Responsible Down Standard 2.0 Released 2Health News:Responsible Down Standard 2.0 Released 3Health News:MedX Pharmacy Offers Skin Care Tips 2
... has been an evident reduction in the breast cancer cases ... this, and one conceivable reason has particularly caught their attention. ... 2002. Whether mere reduction in HRT has brought out such ... has been an almost 7 percent reduction in the number ...
... people with history of unprotected sex to have an ... transmission.// The announcement being the first case of such ... Thursday uncovered two clusters of HIV infections, HIV-1 subtype ... government scientists. They said that both the clusters found ...
... it as a 'citizens raid', Bhopal gas tragedy survivors' ... sub-standard and expired drugs from two medical stores of ... ,"A joint team of four organisations, working for ... recovered many medicines that had crossed their expiry date," ...
... University of Pennsylvania Health System are starting a trial ... its electrical pulses// essentially short-circuit, referred to as atrial ... into with current therapies to cope with electrical rhythmic ... procedures, is that up until now, they’ve had to ...
... while ‘over the limit,’ but subsequently found to be below ... range of drugs, reveals research in Injury Prevention. ... testing in all drivers who are suspected of being over ... findings on 2000 blood and urine specimens taken from drivers ...
... The route to a man’s heart is through his stomach, they ... the kitchen? Food for thought, of course! Meanwhile, what could be ... the attention of the lady of the house, says a new ... embarked on a study of almost 200 British men and women, ...
Cached Medicine News:Health News:New Tool Being Tested to Halt Recurrence of Atrial Fibrillation 2Health News:One in Three Drivers Under ‘The Limit’ for Alcohol Still Test Positive for Dru 2Health News:How a Woman Holds Fort in Her Little Kingdom – The Kitche 2
... Restylane is a ... generated by,Streptococcus species of ... stabilized and suspended in ... = 7 and concentration ...
The HEMOCHRON Model 401 is a portable, single-well whole blood coagulation monitoring instrument. The 401 provides on-screen plasma equivalent PT and APTT test results....
Minimizes imperfections and reduces the visible appearance of cellulite and stretch marks. This formula refines uneven skin texture and improves skin firmness and elasticity to leave you with skin yo...
... delivers clinically proven aminophylline directly to the ... fat reduction with the aminophylline containing cream ... an increase in the firmness of the ... the skin where it causes the body ...
Medicine Products: